{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["6(2)"],"submitter":["Bock JM"],"pubmed_abstract":["<h4>Objective</h4>To determine whether continuous positive airway pressure (CPAP) adherence reduces health care-related costs or use in patients with obstructive sleep apnea (OSA) and comorbid cardiovascular disease (CVD).<h4>Patients</h4>A total of 23 million patients with CVD were identified in the Medicare fee-for-service database. Of the 65,198 who completed a sleep study between January 2016 and September 2018, 55,125 were diagnosed as having OSA and 1758 were identified in the 5% Medicare durable medical equipment (DME) database.<h4>Methods</h4>Patients with DME claims were categorized as adherent (AD, treatment evidenced ≥91 days after CPAP initiation; n=614) or nonadherent (nAD, n=242) to CPAP therapy. In addition, 9881 individuals with CVD who were not diagnosed as having OSA afte"],"journal":["Mayo Clinic proceedings. Innovations, quality & outcomes"],"pagination":["166-175"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8987617"],"repository":["biostudies-literature"],"pubmed_title":["Continuous Positive Airway Pressure Adherence and Treatment Cost in Patients With Obstructive Sleep Apnea and Cardiovascular Disease."],"pmcid":["PMC8987617"],"pubmed_authors":["Ekono MM","Lerman A","Bock JM","Gregory DA","Wickwire EM","Somers VK","Needham KA"],"additional_accession":[]},"is_claimable":false,"name":"Continuous Positive Airway Pressure Adherence and Treatment Cost in Patients With Obstructive Sleep Apnea and Cardiovascular Disease.","description":"<h4>Objective</h4>To determine whether continuous positive airway pressure (CPAP) adherence reduces health care-related costs or use in patients with obstructive sleep apnea (OSA) and comorbid cardiovascular disease (CVD).<h4>Patients</h4>A total of 23 million patients with CVD were identified in the Medicare fee-for-service database. Of the 65,198 who completed a sleep study between January 2016 and September 2018, 55,125 were diagnosed as having OSA and 1758 were identified in the 5% Medicare durable medical equipment (DME) database.<h4>Methods</h4>Patients with DME claims were categorized as adherent (AD, treatment evidenced ≥91 days after CPAP initiation; n=614) or nonadherent (nAD, n=242) to CPAP therapy. In addition, 9881 individuals with CVD who were not diagnosed as having OSA afte","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Apr","modification":"2025-04-26T15:15:11.422Z","creation":"2025-04-06T14:52:56.179Z"},"accession":"S-EPMC8987617","cross_references":{"pubmed":["35399584"],"doi":["10.1016/j.mayocpiqo.2022.01.002"]}}